Beyond Weight Loss: GLP-1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes
Nutrients · 28.11.2025 · 17 (23) · 3735
DOI: 10.3390/nu17233735 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 28.11.2025. Verfasst von Isabel Krug und 4 weiteren Autor:innen. Beteiligte Einrichtung: Melbourne School of Psychological Sciences, The University of Melbourne, Parkville, VIC 3010, Australia. Hauptthemen laut MEDLINE: Feeding and Eating Disorders, Glucagon-Like Peptide-1 Receptor Agonists, Weight Loss, Appetite Regulation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed treatment for higher weight and diabetes. Because they also influence appetite and reward processes, these medications may shape eating behaviours, emotions, and body image, raising new challenges for eating disorder (ED) research and clinical care. This narrative review synthesises emerging evidence on the psychological and behavioural effects of GLP-1RA use within a biopsychosocial and equity framework.
Method
Using a narrative, non-systematic approach, we conducted targeted searches across major databases (2015–September 2025) with combined GLP-1RA and psychological or ED-related terms, supplemented by cross-referencing. Inclusion criteria focused on empirical, theoretical, and clinically meaningful psychological, behavioural, and sociocultural outcomes, enabling a conceptually driven synthesis of the psychological effects of GLP-1RA use.
Results
GLP-1RAs reduce hunger and binge-eating frequency, suggesting possible benefits for binge-type EDs. However, evidence for restrictive EDs remains limited, and appetite suppression may reinforce rigid control or perfectionistic traits. Although short-term reductions in emotional eating have been reported, the long-term psychological safety of GLP-1RAs is unknown. Rapid, medication-driven weight loss may disrupt body perception, while social media discourse glamorises thinness and intensifies stigma. These psychosocial effects intersect with inequities in access, disproportionately affecting adolescents and individuals from culturally diverse or socioeconomically marginalised groups.
Conclusions
GLP-1RAs sit at the intersection of medical innovation and psychological risk. To ensure safe and inclusive use, research and clinical practice should integrate developmental, cultural, and lived-experience perspectives. Co-designed research and multidisciplinary monitoring will be essential to reduce stigma, address inequities, and support psychologically informed care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Melbourne School of Psychological Sciences, The University of Melbourne, Parkville, VIC 3010, Australia.
- School of Psychology and Public Health, La Trobe University, Melbourne, VIC 3083, Australia.
- Allied Health Psychology, Royal Melbourne Hospital, Parkville, VIC 3050, Australia.
- School of Health in Social Science, The University of Edinburgh, Edinburgh EH8 9YL, UK.
ORCID-Profile: Isabel Krug, An Binh Dang, Jade Portingale, Ying Qing Won
Zitieren
APA
Krug, I., Dang, A. B., Portingale, J., Li, Y., & Won, Y. Q. (2025). Beyond Weight Loss: GLP-1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes. Nutrients, 17(23), 3735. https://doi.org/10.3390/nu17233735
Vancouver
Krug I, Dang AB, Portingale J, Li Y, Won YQ. Beyond Weight Loss: GLP-1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes. Nutrients. 2025;17(23):3735. doi:10.3390/nu17233735
BibTeX
@article{Krug2025,
author = {Krug, Isabel and Dang, An Binh and Portingale, Jade and Li, Yakun and Won, Ying Qing},
title = {Beyond Weight Loss: GLP-1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {23},
pages = {3735},
doi = {10.3390/nu17233735}
}
EUVIMED